Roche to acquire Viewics, Inc.
Roche has announced an agreement with Viewics, Inc, a privately held software company focused on laboratory business analytics. Under the agreement, Roche is acquiring all shares of the company.
The acquisition, which is subject to customary closing conditions, is expected to close on 21st November 2017. This acquisition allows Roche to expand its leading position in the Integrated Core Lab with business analytics capabilities, enabling laboratories to make faster data-driven informed decisions about their operations and processes. The cloud-based solution is secure, infrastructure-agnostic, interactive, and accessible from multiple devices (e.g. smartphones, tablets, desktop computers).
“We are excited that Viewics, Inc. will be joining the Roche Group, as it will help us to support our customers around the world in improving their lab performance and processes,” said Roland Diggelmann, CEO Roche Diagnostics. “The Viewics solution offers our customers insights at their fingertips, uncovering potential value and profitability drivers in lab operations, and indicators to improve the overall quality of care”.
“We founded Viewics with the belief that unlocking the value of data would drive immense value for our customers. With Roche’s expertise and strong alignment within our teams, we are excited to embark on this next phase of Viewics’ journey and jointly deliver on this mission,” said Dhiren Bhatia, Founder and President of Viewics, Inc.
“Viewics, Inc. strives to provide unprecedented access to disparate healthcare data to surface actionable insights and empower data-driven decision-making,” said Keith Laughman, CEO of Viewics, Inc. “The Viewics platform generates insights that can inform real-time decisions about costs, laboratory performance, and many other areas affecting today’s modern healthcare organisations. We are looking forward to working with our Roche colleagues in helping to support the lab’s critical role in healthcare delivery.